The commodity nature of green coffee is the main cause of the ‘coffee paradox’ (falling producer prices and rising consumer prices). Geographical Indications (GIs) may be an effective ‘decommodifier’ of the coffee market, but many constraints have to be overcome. Based on an analysis of how the characteristics of the coffee production system shape the positions of local stakeholders and, thus, the GI building process, this article identifies some constraining factors that can seriously undermine the capacity the GI has to decommodify the market and attain a fairer distribution of the benefits for local producers.
The food crisis of 2007 – 08 and the urban riots that ensued in some 40 developing countries placed the question of food price instability at the heart of policy debates. Since the 1980s, the prevailing idea has been that the best solution is managing risk without 'affecting prices' through private instruments (such as crop insurance, futures markets) in conjunction with the provision of safety nets for vulnerable populations. Nevertheless, this strategy did not prove effective: private risk-management instruments did not come to fruition, and safety nets did not succeed in preventing the deteriorating nutritional situation of vulnerable house- holds. This paper shows that the arguments against price stabilisation (the informational role of prices and the 'natural insurance' of producers) do not hold when the different causes of price instability are taken into account. The author proposes a typology of these causes. The paper closes by proposing relevant combinations of instruments for each cause of instability and discussing ways to implement them. (Résumé d'auteur
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.